Cromos Pharma, where the patients are

Drug Sponsors

Sanofi discontinues development of two investigational compounds

Tuesday, June 4, 2013 10:00 AM

Sanofi, a global healthcare company, announced topline results of two phase III clinical studies of investigational compounds iniparib and otamixaban and, as a result, has announced it will discontinue both programs.

More... »

CRF Health eCOA webinar series

UPM purchases Pfizer commercial manufacturing site

Monday, June 3, 2013 11:32 AM

UPM Pharmaceuticals, a Baltimore, Md.-based drug development and contract manufacturer, will acquire the 500,000-square-foot commercial manufacturing facility Pfizer currently operates in Bristol, Tenn.

More... »

Amgen and Astellas announce Japan alliance

Wednesday, May 29, 2013 02:48 PM

Amgen, an independent biotechnology company, and Astellas Pharma, a Tokyo-based global pharmaceutical company, have entered into an alliance to provide new medicines to help address serious unmet medical needs of Japanese patients.

More... »

GSK acquires Okairos, strengthens vaccines business

Wednesday, May 29, 2013 02:44 PM

GlaxoSmithKline (GSK), a research-based pharmaceutical and healthcare company, has acquired Okairos, a specialist developer of vaccine platform technologies, for approximately $325 million in cash.

More... »

Pharmaxis reveals revised business plan, cuts 30% of workforce

Wednesday, May 29, 2013 12:27 PM

Pharmaxis, a specialty pharmaceutical company, has revised its business plan which delivers significant reductions in expenses and increases the focus on partnering strategies to grow the value of the company’s assets and reposition it for the future in the global respiratory drug market.

More... »

Valeant Pharmaceuticals to acquire Bausch + Lomb

Tuesday, May 28, 2013 02:14 PM

Valeant Pharmaceuticals International, based in Quebec, will acquire Rochester, N.Y.-based Bausch + Lomb, the global eye health company, for $8.7 billion in cash.

More... »

Covidien board approves separation of Pharma business, declares dividend of Mallinckrodt ordinary shares

Tuesday, May 28, 2013 08:00 AM

The board of directors of Covidien, a global provider of healthcare products, has approved the separation of the Pharmaceuticals business from the rest of Covidien.

More... »

Forest Laboratories CEO Howard Soloman to retire

Friday, May 24, 2013 10:02 AM

Forest Laboratories, an international pharmaceutical company, announced that Howard Solomon will retire as chief executive officer and president, effective December 31, 2013. Solomon has served as CEO since 1977, chairman since 1998 and president since 2010.

More... »

Merck announces $5B accelerated share repurchase

Wednesday, May 22, 2013 03:46 PM

Merck, a global healthcare company known as MSD outside the U.S. and Canada, has entered into an accelerated share repurchase agreement (ASR) with Goldman, Sachs & Co. to repurchase $5 billion of Merck's common stock. Proceeds from the company's recently concluded debt offering were used to execute the ASR, which is part of Merck's previously announced $15 billion share repurchase program.

More... »

eFFECTOR Therapeutics raises $45M in series A financing

Wednesday, May 22, 2013 11:32 AM

eFFECTOR Therapeutics, a newly established biopharmaceutical company, has completed a $45 million Series A financing. eFFECTOR is focused on inventing and developing small molecule drugs to selectively regulate protein synthesis, also known as translation, with an initial emphasis on cancer. 

More... »

CenterWatch Data Library



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs